Evidence map›Paper›PMID 35684488›Full record

ReviewMolecules (Basel, Switzerland)2022

Pharmacological, Neurochemical, and Behavioral Mechanisms Underlying the Anxiolytic- and Antidepressant-like Effects of Flavonoid Chrysin.

Juan Francisco Rodríguez-Landa, León Jesús German-Ponciano, Abraham Puga-Olguín, Oscar Jerónimo Olmos-Vázquez

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 60 citations in OpenAlex.

  1. The Impact ofNutrients · 2025
    Trial
  2. Review
  3. Review
  4. Effects of chrysin on Kisspeptin, neurokinin B, and dynorphin neurons andInternational journal of reproductive biomedicine · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Anticancer Activity of Ether Derivatives of Chrysin.Molecules (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Juan Francisco Rodríguez-LandaLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa 91190, Mexico.ORCID 0000-0001-5837-103X
León Jesús German-PoncianoLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa 91190, Mexico.
Abraham Puga-OlguínUnidad de Salud Integrativa, Centro de EcoAlfabetización y Diálogo de Saberes, Universidad Veracruzana, Xalapa 91060, Mexico.ORCID 0000-0002-5968-0210
Oscar Jerónimo Olmos-VázquezLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa 91190, Mexico.ORCID 0000-0003-0730-4907
Universidad Veracruzana · MX

Funding

Sistema Nacional de Investigadores - CONACyT-Mexico Exp. 32753 and Exp.84949
6 · The paper itself

Abstract

Chrysin (5,7-dihydroxyflavone) is a flavonoid isolated from plants, such as

Indexed as

Anti-Anxiety AgentsPassifloraAntidepressive AgentsAntioxidantsFlavonoidsAnti-Anxiety AgentsAntidepressive AgentsAntioxidantschrysinFlavonoidsantidepressantanxiolyticchrysinflavonoidnatural medicineneuropharmacology

Identifiers

PMID35684488
PMCPMC9182416
OpenAlexW4281965082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.